International Stem Cell (ISCO) Notes Payables (2018 - 2025)
Historic Notes Payables for International Stem Cell (ISCO) over the last 7 years, with Q3 2025 value amounting to $3.3 million.
- International Stem Cell's Notes Payables fell 154.9% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 154.9%. This contributed to the annual value of $3.4 million for FY2024, which is 179.35% down from last year.
- Latest data reveals that International Stem Cell reported Notes Payables of $3.3 million as of Q3 2025, which was down 154.9% from $3.3 million recorded in Q2 2025.
- Over the past 5 years, International Stem Cell's Notes Payables peaked at $3.5 million during Q2 2024, and registered a low of $2.9 million during Q1 2021.
- For the 5-year period, International Stem Cell's Notes Payables averaged around $3.3 million, with its median value being $3.3 million (2022).
- Its Notes Payables has fluctuated over the past 5 years, first surged by 1908.14% in 2021, then tumbled by 718.14% in 2025.
- Over the past 5 years, International Stem Cell's Notes Payables (Quarter) stood at $2.9 million in 2021, then grew by 12.98% to $3.3 million in 2022, then increased by 3.97% to $3.5 million in 2023, then fell by 1.79% to $3.4 million in 2024, then fell by 2.65% to $3.3 million in 2025.
- Its Notes Payables stands at $3.3 million for Q3 2025, versus $3.3 million for Q2 2025 and $3.4 million for Q1 2025.